Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 May;72(2):207-10.

Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations

Affiliations

Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations

P Ljungman et al. Clin Exp Immunol. 1988 May.

Abstract

Seventeen patients with a history of frequent clinical herpes simplex (HSV) reactivations and 13 HSV seropositive controls were monitored for 6 months. The patients had 4-8 clinical reactivations during the study. No clinical HSV reactivations were observed in the controls. IgG subclasses directed against HSV-1 nucleocapsid, membrane and glycoprotein C (gC) antigens were determined after the study period. Anti-HSV IgG4 directed against gC was found more often in the patients (65%) than in the controls (8%, P less than 0.025). The same trend was seen for IgG4 against HSV nucleocapsid antigen (88 and 46%, n.s.) and HSV membrane antigen (82 and 38%, n.s.). In both patients and controls IgG3 was found more often against nucleocapsid antigen compared to membrane or gC antigens (P less than 0.001). Lymphocytes were stimulated with the different antigens and the anti-HSV IgG subclass responses and cellular proliferation were determined. Lymphocyte produced IgG4 against HSV nucleocapsid antigen was found more often in patients than in controls (47 and 8%, P = 0.05) and membrane antigen (41 and 0%; P less than 0.025). No differences were found in the magnitude of lymphocyte proliferation responses between patients and controls. Lymphocyte proliferation responses were stronger to nucleocapsid antigen than to membrane or gC antigens (P less than 0.01).

PubMed Disclaimer

References

    1. J Infect Dis. 1975 May;131(5):528-34 - PubMed
    1. J Virol Methods. 1981 Apr;2(5):301-12 - PubMed
    1. J Virol Methods. 1982 Apr;4(3):167-76 - PubMed
    1. J Virol Methods. 1982 Nov;5(3-4):219-27 - PubMed
    1. Infect Immun. 1983 Oct;42(1):237-44 - PubMed

LinkOut - more resources